| Devatis AG - Temozolomid Devatis 5 mg, Kapseln | | 68606 | | 01 | | Temozolomid Devatis 5 mg | | Kapseln | | L01AX03 | | Temozolomid | | 17.11.2022 | | |
| | Composition | | temozolomidum 5 mg, lactosum 132.8 mg, carboxymethylamylum natricum A corresp. natrium max. 0.3 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, E 172 (flavum), E 132, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Temozolomide | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Temozolomide | 5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Acidum Stearicum | | | | Acide Tartarique | | | | Ammonii Hydroxidum | | | | Carboxymethylamylum Natricum A | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Lactosum | 132.8 mg | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
